. Author manuscript; available in PMC: 2016 Apr 1.

Published in final edited form as: Pharmacogenet Genomics. 2011 Dec;21(12):867–875. doi: 10.1097/FPC.0b013e32834cebc6

Table 2.

Serum PON1 parameters of Caucasian and African American males and females.

Variables	Units	TotalPop	AAF	AAM	CF	CM
		n = 200	n = 40	n = 40	n = 60	n = 60
POaseNa¹	U/L	401 ± 188	509 ± 183^A	421 ± 189^AB	363 ± 173^B	354 ± 178^B
DZOaseNa¹	U/L	8460 ± 2757	8649 ± 2566^AB	7699 ± 2231^B	9191 ± 3110^A	8130 ± 2741^AB
POase¹	U/L	98 ± 54	129 ± 56^A	104 ± 53^AB	85 ± 50^B	85 ± 50^B
DZOase¹	U/L	6437 ± 2249	6141 ± 1814^A	6033 ± 1858^A	7052 ± 2472^A	6300 ± 2445^A
PhAc¹	U/L	15404 ± 3351	16919 ± 3165^A	15685 ± 3542^AB	14984 ± 3386^B	14656 ± 3041^B
Genotype²
QQ		68	5^A	9^A	29^B	25^B
QR		87	17^A	18^A	25^A	27^A
RR		40	16^A	13^A	5^B	6^B

Activities of POaseNa, DZOaseNa, POase, DZOase, and hydrolysis of PhAc are expressed as micromoles substrate hydrolyzed per minute per liter of serum (U/L), means ± SD.

Number of individuals in each race-gender group with the indicated genotype.

Values within a row with the same superscript letter are not significantly different (p≤ 0.05) as determined by analysis of variance with Tukey adjustment or by analysis of chi-square (χ²) with Bonferroni adjustment.